Advent Pharma Ltd. (DSE:ADVENT)
14.90
-0.10 (-0.67%)
At close: Aug 11, 2025
Nevro Market Cap
Advent Pharma has a market cap or net worth of 1.39 billion as of August 12, 2025. Its market cap has decreased by -42.47% in one year.
Market Cap
1.39B
Enterprise Value
1.46B
Revenue
478.96M
Ranking
n/a
PE Ratio
28.50
Stock Price
$14.90
Market Cap Chart
Since April 12, 2018, Advent Pharma's market cap has decreased from 3.32B to 1.39B, a decrease of -58.21%. That is a compound annual growth rate of -11.21%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 1.39B | -10.78% |
Dec 30, 2024 | 1.56B | -32.93% |
Dec 28, 2023 | 2.32B | -1.97% |
Dec 29, 2022 | 2.37B | -0.74% |
Dec 30, 2021 | 2.38B | 14.47% |
Dec 30, 2020 | 2.08B | 11.96% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
Apr 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Grameenphone | 427.37B |
Square Pharmaceuticals PLC. | 198.74B |
British American Tobacco Bangladesh Company | 157.19B |
Robi Axiata PLC. | 140.38B |
Walton Hi-Tech Industries | 136.20B |
BRAC Bank PLC. | 135.98B |
Bangladesh Export Import Company | 103.85B |
Marico Bangladesh | 89.78B |